Evidence map›Paper›PMID 24191015›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2013

Optimized gene editing technology for Drosophila melanogaster using germ line-specific Cas9.

Xingjie Ren, Jin Sun, Benjamin E Housden, Yanhui Hu, Charles Roesel, Shuailiang Lin, Lu-Ping Liu, Zhihao Yang, Decai Mao, Lingzhu Sun and 7 more

Abstract readEvaluation Study
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 253 papers.

0numbers the graph read from it
0cells of the map it votes in
253citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

253 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Molecular mechanisms and biotechnology applications of CRISPR-Cas12a.Nature reviews. Molecular cell biology · 2026
    Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Review
  12. Article
  13. Nature Inspired Delivery Vehicles for CRISPR-Based Genome Editing.Small (Weinheim an der Bergstrasse, Germany) · 2026
    Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

193 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Xingjie RenGene Regulatory Laboratory, School of Medicine, Tsinghua University, Beijing 100084, China.
Jin Sun
Benjamin E Housden
Yanhui Hu
Charles Roesel
Shuailiang Lin
Lu-Ping Liu
Zhihao Yang
Decai Mao
Lingzhu Sun
Qujie Wu
Jun-Yuan Ji
Jianzhong Xi
Stephanie E Mohr
Jiang Xu
Norbert Perrimon
Jian-Quan Ni

Funding

New collections of dsRNAs and overexpression miRNA constructs to supplement RNAiR01GM067761 · NIGMS · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI PERRIMON, NORBERT · 2003 to 2019
$15.5M
Drosophila Transgenic RNAi Resource ProjectR01GM084947 · NIGMS · HARVARD MEDICAL SCHOOL · PI PERRIMON, NORBERT · 2008 to 2019
$9.8M
Network analysis of Signal TransductionR01DK088718 · NIDDK · HARVARD MEDICAL SCHOOL · PI PERRIMON, NORBERT · 2010 to 2014
$2.5M
Context-specific Functions of CDK8R01DK095013 · NIDDK · TEXAS A&M UNIVERSITY HEALTH SCIENCE CTR · PI JI, JUN-YUAN · 2013 to 2017
$1.5M
Howard Hughes Medical InstituteNIDDK NIH HHS R01 DK088718NIDDK NIH HHS R01 DK095013NIGMS NIH HHS R01 GM067761NIGMS NIH HHS R01 GM084947
6 · The paper itself

Abstract

The ability to engineer genomes in a specific, systematic, and cost-effective way is critical for functional genomic studies. Recent advances using the CRISPR-associated single-guide RNA system (Cas9/sgRNA) illustrate the potential of this simple system for genome engineering in a number of organisms. Here we report an effective and inexpensive method for genome DNA editing in Drosophila melanogaster whereby plasmid DNAs encoding short sgRNAs under the control of the U6b promoter are injected into transgenic flies in which Cas9 is specifically expressed in the germ line via the nanos promoter. We evaluate the off-targets associated with the method and establish a Web-based resource, along with a searchable, genome-wide database of predicted sgRNAs appropriate for genome engineering in flies. Finally, we discuss the advantages of our method in comparison with other recently published approaches.

Indexed as

Germ CellsAnimalsAnimals, Genetically ModifiedCRISPR-Cas SystemsDatabases, GeneticDrosophila melanogasterDrosophila ProteinsGenetic EngineeringGenomicsMutagenesisPromoter Regions, GeneticRNA-Binding ProteinsDrosophila Proteinsnos protein, DrosophilaRNA-Binding ProteinsHRMAnanos-Cas9

Identifiers

PMID24191015
PMCPMC3839733

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.